FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2808652574> ?p ?o ?g. }

• W2808652574 endingPage "3004" @default.
• W2808652574 startingPage "2997" @default.
• W2808652574 abstract "The potential applications for nanomaterials continue to grow as new materials are developed and environmental and safety concerns are more adequately addressed. In particular, virus-like particles (VLPs) have myriad applications in medicine and biology, exploiting both the reliable, symmetric self-assembly mechanism and the ability to take advantage of surface functionalities that may be appropriately modified through mutation or bioconjugation. Herein we describe the design and application of hybrid VLPs for use as potent heparin antagonists, providing an alternative to the toxic heparin antidote protamine. A two-plasmid system was utilized to generate VLPs that contain both the wild-type coat protein and a second coat protein with either a C- or N-terminal cationic peptide extension (4-28 amino acids). Incorporation of the modified coat proteins varied from 8 to 31%, while activated partial thromboplastin time (APTT) assays revealed a range of the heparin antagonist activity. Notably, when examined on the basis of the quantity of peptide delivered due to the varied incorporation rates, it appeared that the VLPs largely followed a similar trend, with the quantity of peptide delivered more closely correlating with heparin antagonist activity. The particle with the highest incorporation rate and best antiheparin activity displayed the C-terminal peptide ARK2A2KA, which corresponds to the Cardin-Weintraub consensus sequence for binding to glycosaminoglycans. Analysis of this particle using heparin affinity chromatography with fraction collection revealed that particles eluting at higher salt concentration had a greater proportion of peptide incorporation. Preliminary dual polarization interferometry experiments further support a strong interaction between this particle and heparin." @default.
• W2808652574 created "2018-06-21" @default.
• W2808652574 creator A5002162128 @default.
• W2808652574 creator A5004865578 @default.
• W2808652574 creator A5006281604 @default.
• W2808652574 creator A5028917026 @default.
• W2808652574 creator A5029858225 @default.
• W2808652574 creator A5041860908 @default.
• W2808652574 creator A5061821786 @default.
• W2808652574 creator A5063274192 @default.
• W2808652574 date "2018-06-14" @default.
• W2808652574 modified "2023-09-26" @default.
• W2808652574 title "Polyvalent Hybrid Virus-Like Nanoparticles with Displayed Heparin Antagonist Peptides" @default.
• W2808652574 cites W1556646709 @default.
• W2808652574 cites W1569064266 @default.
• W2808652574 cites W1873235210 @default.
• W2808652574 cites W1899047754 @default.
• W2808652574 cites W1967547757 @default.
• W2808652574 cites W1972333400 @default.
• W2808652574 cites W1972869225 @default.
• W2808652574 cites W1982423863 @default.
• W2808652574 cites W1983279508 @default.
• W2808652574 cites W1992287383 @default.
• W2808652574 cites W1993868243 @default.
• W2808652574 cites W1994744496 @default.
• W2808652574 cites W2009758397 @default.
• W2808652574 cites W2015532596 @default.
• W2808652574 cites W2018249439 @default.
• W2808652574 cites W2023619243 @default.
• W2808652574 cites W2036287538 @default.
• W2808652574 cites W2048317707 @default.
• W2808652574 cites W2068164380 @default.
• W2808652574 cites W2070195131 @default.
• W2808652574 cites W2079670884 @default.
• W2808652574 cites W2083453090 @default.
• W2808652574 cites W2084557064 @default.
• W2808652574 cites W2092751827 @default.
• W2808652574 cites W2094393536 @default.
• W2808652574 cites W2106246537 @default.
• W2808652574 cites W2140699523 @default.
• W2808652574 cites W2141504315 @default.
• W2808652574 cites W2146031145 @default.
• W2808652574 cites W2146129514 @default.
• W2808652574 cites W2162162777 @default.
• W2808652574 cites W2165286214 @default.
• W2808652574 cites W2333983635 @default.
• W2808652574 cites W2345836393 @default.
• W2808652574 cites W2421275313 @default.
• W2808652574 cites W2476758090 @default.
• W2808652574 cites W2501640039 @default.
• W2808652574 cites W2553045059 @default.
• W2808652574 cites W2611191997 @default.
• W2808652574 cites W2621527800 @default.
• W2808652574 cites W2626547112 @default.
• W2808652574 cites W2760731749 @default.
• W2808652574 cites W4293262123 @default.
• W2808652574 cites W763297284 @default.
• W2808652574 cites W2098985899 @default.
• W2808652574 doi "https://doi.org/10.1021/acs.molpharmaceut.8b00135" @default.
• W2808652574 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/29902009" @default.
• W2808652574 hasPublicationYear "2018" @default.
• W2808652574 type Work @default.
• W2808652574 sameAs 2808652574 @default.
• W2808652574 citedByCount "7" @default.
• W2808652574 countsByYear W28086525742020 @default.
• W2808652574 countsByYear W28086525742021 @default.
• W2808652574 countsByYear W28086525742023 @default.
• W2808652574 crossrefType "journal-article" @default.
• W2808652574 hasAuthorship W2808652574A5002162128 @default.
• W2808652574 hasAuthorship W2808652574A5004865578 @default.
• W2808652574 hasAuthorship W2808652574A5006281604 @default.
• W2808652574 hasAuthorship W2808652574A5028917026 @default.
• W2808652574 hasAuthorship W2808652574A5029858225 @default.
• W2808652574 hasAuthorship W2808652574A5041860908 @default.
• W2808652574 hasAuthorship W2808652574A5061821786 @default.
• W2808652574 hasAuthorship W2808652574A5063274192 @default.
• W2808652574 hasConcept C185592680 @default.
• W2808652574 hasConcept C2777557582 @default.
• W2808652574 hasConcept C2779281246 @default.
• W2808652574 hasConcept C2780835560 @default.
• W2808652574 hasConcept C55493867 @default.
• W2808652574 hasConceptScore W2808652574C185592680 @default.
• W2808652574 hasConceptScore W2808652574C2777557582 @default.
• W2808652574 hasConceptScore W2808652574C2779281246 @default.
• W2808652574 hasConceptScore W2808652574C2780835560 @default.
• W2808652574 hasConceptScore W2808652574C55493867 @default.
• W2808652574 hasFunder F4320306315 @default.
• W2808652574 hasFunder F4320306487 @default.
• W2808652574 hasIssue "8" @default.
• W2808652574 hasLocation W28086525741 @default.
• W2808652574 hasLocation W28086525742 @default.
• W2808652574 hasOpenAccess W2808652574 @default.
• W2808652574 hasPrimaryLocation W28086525741 @default.
• W2808652574 hasRelatedWork W173534854 @default.
• W2808652574 hasRelatedWork W1980832026 @default.
• W2808652574 hasRelatedWork W2023619243 @default.
• W2808652574 hasRelatedWork W2136807780 @default.
• W2808652574 hasRelatedWork W2365147984 @default.

• next